BNGO
Bionano Genomics Inc
Price:  
3.67 
USD
Volume:  
38,512
United States | Life Sciences Tools & Services

Bionano WACC - Weighted Average Cost of Capital

The WACC of Bionano Genomics Inc (BNGO) is 16.9%.

The Cost of Equity of Bionano Genomics Inc (BNGO) is 8.1%.
The Cost of Debt of Bionano Genomics Inc (BNGO) is 45.75%.

RangeSelected
Cost of equity6.9% - 9.3%8.1%
Tax rate0.1% - 0.6%0.35%
Cost of debt7.0% - 84.5%45.75%
WACC6.9% - 26.9%16.9%
WACC

Bionano WACC calculation

CategoryLowHigh
Long-term bond rate3.9%4.4%
Equity market risk premium4.6%5.6%
Adjusted beta0.650.79
Additional risk adjustments0.0%0.5%
Cost of equity6.9%9.3%
Tax rate0.1%0.6%
Debt/Equity ratio
0.310.31
Cost of debt7.0%84.5%
After-tax WACC6.9%26.9%
Selected WACC16.9%

Bionano's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for Bionano:

cost_of_equity (8.10%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.65) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.